XTLB logo

XTLB
XTL Biopharmaceuticals Ltd.

1,468
Mkt Cap
$6.01M
Volume
43,872.00
52W High
$10.28
52W Low
$2.12
Price
$2.54
XTLB Fundamentals
Prev Close
$2.67
Open
$2.74
50D MA
$2.68
Beta
0.49
Avg. Volume
5.52M
Loading...
Loading...
News
all
press releases
Washington Just Opened the Door to Psychedelic Medicine; This Microcap Already Has a Key
The war on mental illness may be entering its most dramatic turning point in a generation. On April 18, President Trump signed an Executive Order directing the FDA to accelerate research and approval pathways for psychedelic therapies including psilocybin and ibogaine, calling them a potential lifeline for Americans suffering from debilitating conditions. Six days later, the FDA followed with formal priority review designations for qualifying psychedelic treatments, signaling that this once fringe sector of biotechnology has landed squarely in the mainstream of U.S. drug policy.Shares of ...
AllPennyStocks.com·11d ago
News Placeholder
More News
News Placeholder
Washington Just Opened the Door to Psychedelic Medicine; This Microcap Already Has a Key
The war on mental illness may be entering its most dramatic turning point in a generation. On April 18, President Trump signed an Executive Order directing the FDA to accelerate research and approval pathways for psychedelic therapies including psilocybin and ibogaine, calling them a potential lifeline for Americans suffering from debilitating conditions. Six days later, the FDA followed with formal priority review designations for qualifying psychedelic treatments, signaling that this once fringe sector of biotechnology has landed squarely in the mainstream of U.S. drug policy.Shares of ...
AllPennyStocks.com·11d ago
News Placeholder
XTLB Stock Surges 90%, Breaches 200-DMA For First Time In Over 3 Months – Here’s What The Acquisition Of Psyga Bio Brings To The Table
XTL Biopharmaceuticals announced the acquisition of Psyga Bio to gain a major foothold in the psychedelic therapeutics industry.
Stocktwits·11d ago
News Placeholder
Wall Street’s Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets
The biotech and health-tech landscape is entering a new acceleration phase, driven by regulatory momentum, AI integration, and a surge in precision medicine. $NEO, $TGNT, $XTLB, $SAGT, $PRCH, $AKAN
24-7 Market News·11d ago
News Placeholder
XAIR Stock More Than Doubled Today — What’s Driving The Rally?
Beyond Air said that IP portfolio company XTL will acquire 85% of its subsidiary NeuroNOS.
Stocktwits·4mo ago
News Placeholder
CommScope Stock Rockets 91% As Retail Bulls Cheer $10.5B Asset Sale: ‘Get In While It’s Cheap!’
Once the sale is completed and all financial obligations are settled, CommScope intends to return surplus funds to investors.
Stocktwits·9mo ago
<
...
1
>

Latest XTLB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.